Regardless of the SP, this company has to be one of the most interesting on the ASX. It could end up in the gutter or a block buster, I don't really know which.
The history of its journey so far is the type of thing the should be taught in senior school business classes.
The lessons in investor psychology alone have been invaluable, if only we could be privy to the boardroom dealings when it comes to financing the company. I think there would be plenty of lessons to be learnt there. History suggests that the board will pull another rabbit out of the hat to live another day.
Ann: Update on Novartis Agreement, page-210
-
- There are more pages in this discussion • 641 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |